Now showing items 1-1 of 1
What Have We GAINed? An Analysis of Federal Incentive Policies in the Orphan and Anti-Infective Drug Markets
The world faces a growing danger in the form of antibiotic resistance and a dwindling anti-infective pipeline. To help combat the threat, Congress passed legislation (the “GAIN Act”) in 2012 that grants five years of additional ...